143 related articles for article (PubMed ID: 24667720)
1. Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
Timilshina N; Breunis H; Brandwein JM; Minden MD; Gupta V; O'Neill S; Tomlinson GA; Buckstein R; Li M; Alibhai SMH
Ann Oncol; 2014 Apr; 25(4):883-888. PubMed ID: 24667720
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age.
Alibhai SM; Breunis H; Timilshina N; Brignardello-Petersen R; Tomlinson G; Mohamedali H; Gupta V; Minden MD; Li M; Buckstein R; Brandwein JM
J Geriatr Oncol; 2015 Jul; 6(4):262-71. PubMed ID: 25944029
[TBL] [Abstract][Full Text] [Related]
3. Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy.
Timilshina N; Breunis H; Tomlinson GA; Brandwein JM; Buckstein R; Durbano S; Alibhai SMH
Leukemia; 2019 Jan; 33(1):15-25. PubMed ID: 29884902
[TBL] [Abstract][Full Text] [Related]
4. Do quality of life, physical function, or the Wheatley index at diagnosis predict 1-year mortality with intensive chemotherapy in older acute myeloid leukemia patients?
Timilshina N; Breunis H; Tomlinson G; Brandwein J; Alibhai SM
Leuk Res; 2016 Aug; 47():142-8. PubMed ID: 27337292
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.
Slavin SD; Fenech A; Jankowski AL; Abel GA; Brunner AM; Steensma DP; Fathi AT; DeAngelo DJ; Wadleigh M; Hobbs GS; Amrein PC; Stone RM; Temel JS; El-Jawahri A
Cancer; 2019 Nov; 125(21):3845-3852. PubMed ID: 31299106
[TBL] [Abstract][Full Text] [Related]
6. Association of Days Alive and at Home at Day 90 After Intensive Care Unit Admission With Long-term Survival and Functional Status Among Mechanically Ventilated Patients.
Taran S; Coiffard B; Huszti E; Li Q; Chu L; Thomas C; Burns S; Robles P; Herridge MS; Goligher EC
JAMA Netw Open; 2023 Mar; 6(3):e233265. PubMed ID: 36929399
[TBL] [Abstract][Full Text] [Related]
7. Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit.
Halpern AB; Culakova E; Walter RB; Lyman GH
JAMA Oncol; 2017 Mar; 3(3):374-381. PubMed ID: 27832254
[TBL] [Abstract][Full Text] [Related]
8. A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete Remission.
Cheng MJ; Smith BD; Hourigan CS; Gojo I; Pratz KW; Blackford AL; Mehta AK; Smith TJ
J Palliat Med; 2017 Nov; 20(11):1267-1273. PubMed ID: 28537498
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
[TBL] [Abstract][Full Text] [Related]
10. Performance of the frailty index in predicting complete remission, intensive care unit admission, and overall mortality in older and younger patients with acute myeloid leukemia receiving intensive chemotherapy.
Petrov D; Timilshina N; Papadopoulos E; Alibhai SMH
Leuk Lymphoma; 2022 Sep; 63(9):2189-2196. PubMed ID: 35452363
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.
Schellongowski P; Staudinger T; Kundi M; Laczika K; Locker GJ; Bojic A; Robak O; Fuhrmann V; Jäger U; Valent P; Sperr WR
Haematologica; 2011 Feb; 96(2):231-7. PubMed ID: 21071501
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study.
Roze des Ordons AL; Chan K; Mirza I; Townsend DR; Bagshaw SM
BMC Cancer; 2010 Sep; 10():516. PubMed ID: 20920175
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
Filì C; Candoni A; Zannier ME; Olivieri J; Imbergamo S; Caizzi M; Nadali G; Di Bona E; Ermacora A; Gottardi M; Facchinelli D; Ciancia R; Lazzarotto D; Dubbini MV; Festini G; Gherlinzoni F; Michieli MG; Semenzato G; Fanin R
Leuk Res; 2019 Jan; 76():33-38. PubMed ID: 30529681
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit.
Jackson K; Mollee P; Morris K; Butler J; Jackson D; Kruger P; Klein K; Kennedy G
Leuk Lymphoma; 2014 Jan; 55(1):97-104. PubMed ID: 23597137
[TBL] [Abstract][Full Text] [Related]
15. Improved survival rates of AML patients following admission to the intensive care unit.
Fassbind P; Jeker B; Mueller BU; Bacher U; Zimmerli S; Endrich O; Gahl B; Novak U; Pabst T
Leuk Lymphoma; 2019 Oct; 60(10):2423-2431. PubMed ID: 30943056
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
18. Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers.
Salas M; Henderson M; Wientzek-Fleischmann A; Islam Z; Tu N; Bilitou A; Elsharkawy M; Stellmacher U
Front Pharmacol; 2020; 11():1109. PubMed ID: 32792948
[TBL] [Abstract][Full Text] [Related]
19. Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia.
Alibhai SM; Leach M; Gupta V; Tomlinson GA; Brandwein JM; Saiz FS; Minden MD
Crit Rev Oncol Hematol; 2009 Feb; 69(2):168-74. PubMed ID: 18778950
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.
Oeyen SG; Benoit DD; Annemans L; Depuydt PO; Van Belle SJ; Troisi RI; Noens LA; Pattyn P; Decruyenaere JM
Intensive Care Med; 2013 May; 39(5):889-98. PubMed ID: 23248039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
